Treatment | Overall NÂ =Â 197 | Zone 1 NÂ =Â 71 | Zone 2 NÂ =Â 126 | P value | |||
---|---|---|---|---|---|---|---|
n | (%) | n | (%) | n | (%) | ||
Place where malaria patients get treated | |||||||
 At VMW/MMW’s home | 193 | 98.0 | 71 | 100.0 | 122 | 96.8 | 0.129 |
 At the patient’s home | 156 | 79.2 | 61 | 85.9 | 95 | 75.4 | 0.081 |
 Othera | 2 | 1.02 | 0 | 0.0 | 2 | 1.6 | 0.286 |
Malaria patient is directly-observed for the first dose of medication | |||||||
 Yes | 194 | 98.5 | 70 | 98.6 | 124 | 98.4 | 0.693 |
 No | 2 | 1.0 | 1 | 1.4 | 1 | 0.79 | |
 Sometimes | 1 | 0.5 | 0 | 0 | 1 | 0.79 | |
Malaria patient is directly-observed for the 2nd and 3rd days of treatment | |||||||
 Yes | 112 | 56.9 | 35 | 49.3 | 77 | 61.1 | 0.265 |
 No | 27 | 13.7 | 12 | 16.9 | 15 | 11.9 | |
 Sometimes | 58 | 29.4 | 24 | 33.8 | 34 | 27.0 | |
Barriers faced when providing directly-observed treatment | |||||||
 Problem of transportation to patients’ home | 151 | 76.7 | 65 | 91.6 | 86 | 68.3 | 0.000 |
 Long distance to patients home | 149 | 75.6 | 63 | 88.73 | 86 | 68.3 | 0.001 |
 Self-treatment | 26 | 13.2 | 5 | 7.0 | 21 | 16.7 | 0.055 |
 The patient disagreed | 24 | 12.2 | 10 | 14.1 | 14 | 11.1 | 0.540 |
 No knowledge of malaria drug resistance | 21 | 10.7 | 5 | 7.0 | 16 | 12.7 | 0.217 |
 Treatment with other providers | 3 | 1.5 | 0 | 0.0 | 3 | 2.4 | 0.190 |
 Otherc | 2 | 1.0 | 0 | 0.0 | 2 | 1.0 | 0.286 |
 Don’t knowb | 11 | 5.6 | 0 | 0.0 | 11 | 8.7 | 0.537 |